Prognostic value of systemic immune-inflammation index in patients with urologic cancers: a meta-analysis
Open Access
- 12 October 2020
- journal article
- review article
- Published by Springer Nature in Cancer Cell International
- Vol. 20 (1) , 1-8
Abstract
Background: Several studies have reported that the systemic immune-inflammation index (SII) is associated with the prognosis of patients with urologic cancers (UCs). The aim of this study was to systematically evaluate the prognostic value of SII in UC patients.Methods: We searched public databases for relevant published studies on the prognostic value of SII in UC patients. Hazard ratios (HRs) and 95% confidence intervals (CIs) were extracted and pooled to assess the relationships between SII and overall survival (OS), progression-free survival (PFS), cancer-specific survival (CSS), overall response rate (ORR) and disease control rate (DCR).Results: A total of 14 studies with 3074 patients were included. From the pooled results, we found that high SII was associated with worse overall survival (OS) in patients with UC (HR 2.58, 95% CI 1.59–4.21). Patients with high SII values also had poorer PFS (HR 1.92, 95% CI 1.29–2.88) and CSS (HR 2.58, 95% CI 1.36–4.91) as well as lower ORRs (HR 0.40, 95% CI 0.22–0.71) than patients with low SII values. In addition, the subgroup analysis of OS and PFS showed that the prognosis of patients with high SII was worse than that of patients with low SII.Conclusions: SII might be a promising noninvasive predictor in patients with UC. However, more samples and multicenter studies are needed to confirm the effectiveness of SII in predicting the prognosis of patients with UC.Keywords
This publication has 30 references indexed in Scilit:
- Systemic immune-inflammation index, thymidine phosphorylase and survival of localized gastric cancer patients after curative resectionOncotarget, 2016
- Role of platelets in cancer and cancer-associated thrombosis: Experimental and clinical evidencesThrombosis Research, 2016
- Cancer statistics, 2016CA: A Cancer Journal for Clinicians, 2016
- Androgen deprivation of prostate cancer: Leading to a therapeutic dead endCancer Letters, 2015
- Neutrophils: important contributors to tumor progression and metastasisCancer and Metastasis Reviews, 2015
- Systemic Immune-inflammation Index, Based on Platelet Counts and Neutrophil-Lymphocyte Ratio, Is Useful for Predicting Prognosis in Small Cell Lung CancerThe Tohoku Journal of Experimental Medicine, 2015
- Neutrophils contribute to inflammatory lymphangiogenesis by increasing VEGF-A bioavailability and secreting VEGF-DBlood, 2013
- Direct Signaling between Platelets and Cancer Cells Induces an Epithelial-Mesenchymal-Like Transition and Promotes MetastasisCancer Cell, 2011
- Neutrophil granulocyte derived MMP-9 is a VEGF independent functional component of the angiogenic switch in pancreatic ductal adenocarcinomaAngiogenesis, 2011
- Cancer-related inflammationNature, 2008